Sparta Commercial Services (SRCO) Research & Development (2022)
Sparta Commercial Services (SRCO) posted Research & Development of $41969.0 for Q3 2022.
Powered by 
Analysis
Sparta Commercial Services (SRCO) Research & Development (2022) Analysis & Trends
Sparta Commercial Services has reported Research & Development for 1 years, with the latest figure at $41969.0 in Q3 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Orix | 44.91 Bn | 45.24 Bn | 4.68 Bn | - |
| 2 | Royalty Pharma | 36.78 Bn | 38.89 Bn | - | 97.90 Mn |
| 3 | Royal Gold | 22.19 Bn | 22.06 Bn | 390.45 Mn | - |
| 4 | OR Royalties | 6.98 Bn | 6.91 Bn | 82.22 Mn | -1.97 Mn |
| 5 | Encore Capital | 2.06 Bn | 1.88 Bn | 455.04 Mn | - |
| 6 | Atlanticus Holdings | 1.41 Bn | 853.17 Mn | 686.46 Mn | - |
| 7 | Jefferson Capital | 1.23 Bn | 1.21 Bn | - | - |
| 8 | Upbound | 1.11 Bn | 1.00 Bn | 594.84 Mn | - |
| 9 | Lufax Holding | 1.08 Bn | -1.19 Bn | - | -138.98 Mn |
| 10 | Sparta Commercial Services | 4.29 Mn | 5.20 Mn | 51,788.00 | - |